Bank of New York Mellon
PRLD icon

Bank of New York Mellon’s Prelude Therapeutics PRLD Stock Holding History

Bank of New York Mellon’s Portfolio PRLD Stock Details PRLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$363K Buy
+68,187
New +$297K ﹤0.01% 3902
2025
Q2 		– Sell
-28,613
Closed -$22K – 4237
2025
Q1 		$22K Hold
28,613
– – ﹤0.01% 4086
2024
Q4 		$36.5K Hold
28,613
– – ﹤0.01% 4092
2024
Q3 		$59.2K Sell
28,613
-7,663
-21% -$35.5K ﹤0.01% 4037
2024
Q2 		$138K Sell
36,276
-3,792
-9% -$15.4K ﹤0.01% 4000
2024
Q1 		$190K Sell
40,068
-10,532
-21% -$41K ﹤0.01% 3947
2023
Q4 		$216K Buy
50,600
+17,718
+54% +$53.9K ﹤0.01% 3927
2023
Q3 		$102K Buy
32,882
+2,066
+7% +$7.75K ﹤0.01% 4077
2023
Q2 		$139K Buy
+30,816
New +$184K ﹤0.01% 4048
2023
Q1 		– Sell
-28,879
Closed -$174K – 4431
2022
Q4 		$174K Sell
28,879
-300
-1% -$1.92K ﹤0.01% 4011
2022
Q3 		$193K Sell
29,179
-10
-0% -$67 ﹤0.01% 4032
2022
Q2 		$153K Sell
29,189
-30,631
-51% -$156K ﹤0.01% 4142
2022
Q1 		$412K Buy
59,820
+2,144
+4% +$19.6K ﹤0.01% 3828
2021
Q4 		$718K Buy
57,676
+23,364
+68% +$380K ﹤0.01% 3576
2021
Q3 		$1.07M Buy
34,312
+4,058
+13% +$131K ﹤0.01% 3352
2021
Q2 		$866K Sell
30,254
-782
-3% -$27.8K ﹤0.01% 3505
2021
Q1 		$1.34M Buy
31,036
+63
+0.2% +$4.18K ﹤0.01% 3165
2020
Q4 		$2.22M Buy
+30,973
New +$1.54M ﹤0.01% 2785

Other funds holding PRLD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return
SOW
State of Wyoming Cheyenne, Wyoming $989M AUM 52.24% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
SIM
Spark Investment Management New York $51.2M AUM 87.14% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

Bank of New York Mellon's PRLD Position: Q2 2026 in Review

Bank of New York Mellon opened a new position in Prelude Therapeutics (PRLD) in Q2 2026: 68,187 shares worth $363K. The stake represents ﹤0.01% of the portfolio and ranks #3902 among its holdings. This is a return to the name: Bank of New York Mellon previously reported a position in PRLD as recently as Q1 2025.

Bank of New York Mellon first reported a position in PRLD in Q4 2020 and has held it in 18 quarters since. The position peaked at $2.22M in Q4 2020. 19 funds tracked by Wall St. Rank hold PRLD as of Q2 2026.

  • Bank of New York Mellon held 68,187 shares of Prelude Therapeutics worth $363K as of Q2 2026.
  • Prelude Therapeutics was a new Bank of New York Mellon position in Q2 2026.
  • Prelude Therapeutics made up ﹤0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #3902 holding.
  • Bank of New York Mellon first reported a position in Prelude Therapeutics in Q4 2020 and has held it in 18 quarters since.
  • Bank of New York Mellon's Prelude Therapeutics position peaked at $2.22M in Q4 2020.
  • 19 funds tracked by Wall St. Rank held Prelude Therapeutics as of Q2 2026.

Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.